Mikayo Toba

Tokyo Medical and Dental University

Papers

1

Total Citations

6

H-Index

1

About

Dr. Mikayo Toba is a leading urological surgeon and researcher whose work centers on the safety, trends, and real-world outcomes of minimally invasive kidney cancer surgery. Her most impactful research provides a critical, nationwide evaluation of robot-assisted partial nephrectomy (RAPN) during its initial adoption phase in Japan following government approval in 2016. Analyzing data from over 3,700 cases, Dr. Toba’s landmark 2021 study (cited 6 times) documented the rapid uptake and reassuring safety profile of this complex procedure, offering vital evidence for surgical protocols and health policy. This work has established her as a key voice in surgical quality and patient safety, bridging the gap between technological innovation and clinical practice. By leveraging large-scale national databases, Dr. Toba provides the robust, population-level data essential for guiding surgeons and improving outcomes for patients with renal tumors. Her contributions are foundational for researchers and clinicians navigating the adoption of advanced robotic techniques in urology.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Trends and safety of robot‐assisted partial nephrectomy during the initial 2‐year period after government approval in Japan: A nationwide database study from 2016 to 2018
6 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Tokyo Medical and Dental University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago